Figure 4
Figure 4. Hemolysis induces platelet aggregation and mitochondrial dysfunction. (A-D) Platelet activation measured by surface p-selectin expression (A) or percent of activated glycoprotein IIb/IIIa (B), platelet aggregation 15 minutes after treatment (C), and complex V activity (D) in untreated (control) healthy platelets or those exposed to free hemoglobin or oligomycin (0.4 µmol/L) or ADP (20 µM, to stimulate aggregation). (E) Basal respiratory rate (solid line) and mitochondrial hyperpolarization (dashed line) in healthy platelets exposed to increasing concentrations of free hemoglobin. (F) H2O2 generation in hemoglobin-treated platelets (n = 5, *P < .01 vs untreated).

Hemolysis induces platelet aggregation and mitochondrial dysfunction. (A-D) Platelet activation measured by surface p-selectin expression (A) or percent of activated glycoprotein IIb/IIIa (B), platelet aggregation 15 minutes after treatment (C), and complex V activity (D) in untreated (control) healthy platelets or those exposed to free hemoglobin or oligomycin (0.4 µmol/L) or ADP (20 µM, to stimulate aggregation). (E) Basal respiratory rate (solid line) and mitochondrial hyperpolarization (dashed line) in healthy platelets exposed to increasing concentrations of free hemoglobin. (F) H2O2 generation in hemoglobin-treated platelets (n = 5, *P < .01 vs untreated).

Close Modal

or Create an Account

Close Modal
Close Modal